| Literature DB >> 26783557 |
Carlos Placer1, Jose M Enriquez-Navascués1, Ander Timoteo1, Garazi Elorza1, Nerea Borda1, Lander Gallego1, Yolanda Saralegui1.
Abstract
Introduction. The objective of this study was to determine the recurrence rate and associated risk factors of full-thickness rectal prolapse in the long term after Delorme's procedure. Patients and Methods. The study involved adult patients with rectal prolapse treated with Delorme's surgery between 2000 and 2012 and followed up prospectively in an outpatient unit. We assessed epidemiological data, Wexner constipation and incontinence score, recurrence patterns, and risk factors. Data were analyzed by univariate and multivariate studies and follow-up was performed according to Kaplan-Meier technique. The primary outcome was recurrence. Results. A total of 42 patients, where 71.4% (n = 30) were women, with a median age of 76 years (IQR 66 to 86), underwent Delorme's surgery. The median follow-up was 85 months (IQR 28 to 132). There was no mortality, and morbidity was 9.5%. Recurrence occurred in five patients (12%) within 14 months after surgery. Actuarial recurrence at five years was 9.9%. According to the univariate analysis, constipation and concomitant pelvic floor repair were the only factors found to be associated with recurrence. Multivariate analysis showed no statistically significant differences among variables studied. Kaplan-Meier estimate revealed that constipation was associated with a higher risk of recurrence (log-rank test, p = 0.006). Conclusions. Delorme's procedure is a safe technique with an actuarial recurrence at five years of 9.9%. The outcomes obtained in this study support the performance of concomitant postanal repair and levatorplasty to reduce recurrences. Also, severe constipation is associated with a higher recurrence rate.Entities:
Year: 2015 PMID: 26783557 PMCID: PMC4689976 DOI: 10.1155/2015/920154
Source DB: PubMed Journal: Surg Res Pract ISSN: 2356-6124
Baseline characteristics of rectal prolapse patients.
| Total | No recurrence | Recurrence |
| |
|---|---|---|---|---|
| Median age (years) | 76 | 72 | 86 | 0.180£ |
| Sex (men/women) | 12/30 | 10/27 | 2/3 | 0.613¥ |
| ASA (%) | ||||
| I | 2 (4.8) | 2 (5.5) | 0 (0) | |
| II | 12 (28.5) | 11 (29.7) | 1 (25) | |
| III | 28 (66.7) | 24 (64.8) | 4 (75) | 0.753¥ |
| Hysterectomy | 14/16 | 11/16 | 3/0 | 0.090¥ |
| Genital prolapse | 8/22 | 7/20 | 1/2 | 0.954¥ |
| Incontinence (yes/no) | 15/27 | 13/24 | 2/3 | 0.831¥ |
| Constipation (yes/no) | 7/35 | 4/33 | 3/2 | 0.026¥ |
| Prolapse size | ||||
| <5 cms (%) | 24 (57) | 23 (61) | 1 (20) | |
| >5 cms (%) | 18 (43) | 14 (39) | 4 (80) | 0.138¥ |
| Anaesthesia (spinal/gral.) | 31/11 | 30/7 | 1/4 | 0.013¥ |
| Levatorplasty (yes/no) | 7/23 | 7/20 | 0/3 | 0.010¥ |
| Median hospital stay (days) | 5 | 5 | 5 | 0.269£ |
| Median follow-up (months) | 85 | 104 | 43 | 0.144£ |
| Complications (yes/no) | 4/38 | 3/34 | 1/4 | 0.410¥ |
Data for 30 women; £Mann-Whitney; Chi2.
Figure 1Probability of no recurrence after Delorme procedure (Global series).
Figure 2Comparison of probability of no recurrence with time for patients according to age (Kaplan-Meier method).
Figure 3Comparison of probability of no recurrence with time for patients according to constipation (Kaplan-Meier method).
Multivariate analysis.
| Total | No recurrence | Recurrence |
| OR (IC 95%) | |
|---|---|---|---|---|---|
| Anaesthesia (spinal/general) | 31/11 | 30/7 | 1/4 | 0.047¥ | 0.07 (0.005–0.949) |
| Constipation (yes/no) | 7/35 | 4/33 | 3/2 | 0.228¥ | 0.21 (0.017–2.656) |
| Prolapse size | |||||
| <5 cms (%) | 24 (57) | 23 (61) | 1 (20) | ||
| >5 cms (%) | 18 (43) | 14 (39) | 4 (80) | 0.483¥ | 0.414 (0.035–4.858) |
| Levatorplasty (yes/no) | 7/23 | 7/20 | 0/3 | 1¥ | 0.464 (0–) |
| Hysterectomy | 14/16 | 11/16 | 3/0 | 1¥ | 0.730 (0–) |
Data for 30 women; £Mann-Whitney; Chi2.
Functional outcomes of Delorme's procedure.
| Total | No recurrence | Recurrence |
| |
|---|---|---|---|---|
| Constipation (Wexner) | 7/35 | 4/33 | 3/2 | 0.026¥ |
| Baseline (median, IR) | 16.28 (8–21) | 14.82 (6–19) | 14.40 (8–19) | |
| Postoperative (median, IR) | 12.82 (8–18) | 13.82 (6–19) | 11.33 (5–18) | |
| Incontinence (Wexner) | 15/27 | 13/24 | 2/3 | 0.831£ |
| Baseline (median, IR) | 7.9 (4–12) | 7.8 (4–12) | 7.9 (4–12) | |
| Postoperative (median, IR) | 7.4 (4–11) | 7.6 (4–12) | 7.4 (4–11) |
Mann-Whitney; Chi2.